Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,725 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,608 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00259285 | Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer | terminated | Phase 2 | 10 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 2, 2009 | clinicaltrials |
| NCT00475657 | Pemetrexed and Cisplatin as Treatment in Small Cell Lung Cancer | terminated | Phase 2 | 5 | Eli Lilly and CompanyINDUSTRY | 1 | May 29, 2009 | clinicaltrials |
| NCT00435578 |
| Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma |
| terminated |
| Phase 2 |
| 50 |
| Threshold PharmaceuticalsINDUSTRY |
| 1 |
| Apr 30, 2009 |
| clinicaltrials |
| NCT00174369 | MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer | terminated | Phase 2 | 34 | PfizerINDUSTRY | 1 | Mar 17, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00161278 | Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling | terminated | Phase 2 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00535015 | Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer | terminated | Phase 2 | 70 | AnaborexINDUSTRY | 2 | Jul 22, 2008 | clinicaltrials |
| NCT00607425 | Saliva mRNA Expression Profiling for Early Stage Non-Small Cell Lung Cancer Screening(SPIT-LC) | terminated | — | 40 | Scottsdale HealthcareOTHER | 0 | Jul 17, 2008 | clinicaltrials |
| NCT00263016 | Docetaxel in Non Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 50 | SanofiINDUSTRY | 1 | Mar 20, 2008 | clinicaltrials |
| NCT00098917 | Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | terminated | Phase 1 | 15 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 28, 2008 | clinicaltrials |
| NCT00215748 | Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel | terminated | Phase 2 | 40 | Geriatric Oncology ConsortiumOTHER | 1 | Nov 16, 2007 | clinicaltrials |
| NCT00061646 | Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 2 | 25 | AbbottINDUSTRY | 1 | Aug 14, 2007 | clinicaltrials |
| NCT00243204 | Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00290017 | Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy | terminated | Phase 3 | 400 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00316433 | Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer | terminated | Phase 2 | 24 | Swedish Medical CenterOTHER | 1 | Apr 5, 2007 | clinicaltrials |
| NCT00232128 | Protocol for Radiofrequency Ablation of Pulmonary Neoplasms | terminated | N/A | — | Oncology Specialties, AlabamaOTHER | 1 | Jan 12, 2007 | clinicaltrials |
| NCT00420862 | The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography | terminated | Phase 3 | 2,400 | Istituto Clinico HumanitasOTHER | 1 | Jan 11, 2007 | clinicaltrials |
| NCT00241267 | Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease | terminated | — | 20 | University Hospital, ToursOTHER | 1 | Oct 6, 2006 | clinicaltrials |
| NCT00064636 | Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | terminated | Phase 1 | 46 | Millennium Pharmaceuticals, Inc.INDUSTRY | 0 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jun 2, 2009source: clinicaltrials